Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) –Positive Breast Cancer After Prior HER2-Directed Therapy
Howard A. Burris, Hope S. Rugo, Svetislava J. Vukelja, Charles L. Vogel, R. Borson, Steven Limentani, Elizabeth Tan-Chiu, Ian E. Krop, Richard A. Michaelson, Sandhya Girish, Lukas C. Amler, Maoxia Zheng, Yu-Waye Chu, Barbara Klencke, Joyce O’Shaughnessy
Journal of Clinical Oncology, 2010
Abstract
This research paper explore the methodology and findings associated with Journal of Clinical Oncology. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).